# Observational, Prospective, Multi-centric Study Exploring HER2 Mutations Incidence and Therapeutic Management in aNSCLC

> **NCT07356544** · — · RECRUITING · sponsor: **Gruppo Oncologico Italiano di Ricerca Clinica** · enrollment: 50 (estimated)

## Conditions studied

- NSCLC (Advanced Non-small Cell Lung Cancer)
- HER2

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07356544
- **Lead sponsor:** Gruppo Oncologico Italiano di Ricerca Clinica
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-12
- **Primary completion:** 2027-01-31
- **Final completion:** 2027-01-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-03-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07356544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07356544, "Observational, Prospective, Multi-centric Study Exploring HER2 Mutations Incidence and Therapeutic Management in aNSCLC". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07356544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*